Invention Application
- Patent Title: METHODS FOR PREVENTING CANCER RELAPSE
-
Application No.: PCT/US2022/015905Application Date: 2022-02-10
-
Publication No.: WO2022173895A1Publication Date: 2022-08-18
- Inventor: KENNEDY, Thomas, P. , PATEL, Bhaumik, B.
- Applicant: VIRGINIA COMMONWEALTH UNIVERSITY , GLYCOMIRA THERAPEUTICS, INC. , DEPARTMENT OF VETERANS AFFAIRS
- Applicant Address: Bio Tech One, 3rd Floor, Suite 3000; 675 Arapeen Drive, Suite 302; Technology Transfer Program (14RDTT)
- Assignee: VIRGINIA COMMONWEALTH UNIVERSITY,GLYCOMIRA THERAPEUTICS, INC.,DEPARTMENT OF VETERANS AFFAIRS
- Current Assignee: VIRGINIA COMMONWEALTH UNIVERSITY,GLYCOMIRA THERAPEUTICS, INC.,DEPARTMENT OF VETERANS AFFAIRS
- Current Assignee Address: Bio Tech One, 3rd Floor, Suite 3000; 675 Arapeen Drive, Suite 302; Technology Transfer Program (14RDTT)
- Agency: THOMAS HORSTEMEYER LLP
- Priority: US63/148,245 2021-02-11
- Main IPC: A61K31/727
- IPC: A61K31/727 ; A61K31/728 ; A61K31/737 ; A61P35/00
Abstract:
Described herein are methods for preventing a relapse of cancer in a subject. The methods involve administering to the subject in need thereof a sulfated glycosaminoglycan or the pharmaceutically acceptable salt or ester thereof. In one aspect, the methods described herein prevent the growth or self-renewal of cancer stem cells in a subject. In another aspect, the methods described herein kill active or dormant cancer stem cells in a subject. The methods described herein can be used in combination with chemotherapy and/or radiation. The methods described herein are versatile with respect to preventing the relapse of a number of different cancers.
Information query
IPC分类: